OncoImmunology (Jan 2020)

Staphylococcus aureus alpha-toxin inhibits CD8+ T cell-mediated killing of cancer cells in cutaneous T-cell lymphoma

  • Edda Blümel,
  • Shamaila Munir Ahmad,
  • Claudia Nastasi,
  • Andreas Willerslev-Olsen,
  • Maria Gluud,
  • Simon Fredholm,
  • Tengpeng Hu,
  • Bas G. J. Surewaard,
  • Lise M. Lindahl,
  • Hanne Fogh,
  • Sergei B. Koralov,
  • Lise Mette Rahbek Gjerdrum,
  • Rachael A. Clark,
  • Lars Iversen,
  • Thorbjørn Krejsgaard,
  • Charlotte Menné Bonefeld,
  • Carsten Geisler,
  • Jürgen C. Becker,
  • Anders Woetmann,
  • Mads Hald Andersen,
  • Terkild Brink Buus,
  • Niels Ødum

DOI
https://doi.org/10.1080/2162402X.2020.1751561
Journal volume & issue
Vol. 9, no. 1

Abstract

Read online

Staphylococcus aureus and its toxins have been linked to disease progression and mortality in advanced stages of cutaneous T-cell lymphoma (CTCL). CD8+ T cells play a crucial role in anti-cancer responses and high CD8+ T cell numbers in tumor lesions are associated with a favorable prognosis in CTCL. Here, we show that CD8+ T cells from both healthy donors and Sézary syndrome patients are highly susceptible to cell death induced by Staphylococcal alpha-toxin, whereas malignant T cells are not. Importantly, alpha-toxin almost completely blocks cytotoxic killing of CTCL tumor cells by peptide-specific CD8+ T cells, leading to their escape from induced cell death and continued proliferation. These findings suggest that alpha-toxin may favor the persistence of malignant CTCL cells in vivo by inhibiting CD8+ T cell cytotoxicity. Thus, we propose a novel mechanism by which colonization with Staphylococcus aureus may contribute to cancer immune evasion and disease progression in CTCL.

Keywords